Doctor and Patient hemonc2 CMYK low resOur subspecialty training program in pediatric hematology/oncology provides the educational environment for residents to develop an understanding of the pathophysiology of pediatric hematologic and oncologic disorders and competence in the clinical diagnosis and management of these disorders. The program emphasizes the fundamentals of clinical diagnosis, with special emphasis on history taking and physical examination, and provides sufficient clinical experience with both inpatients and outpatients who have hematologic and oncologic disorders to allow residents to develop skill in diagnosing and managing both common and unusual problems.
Click here to download the goals and objectives for Pediatric Hematology/Oncology Fellows.

Program Information

  • The objectives of the training program in Pediatric Hematology/Oncology are to prepare the fellow for an academic career in Pediatric Hematology/Oncology and to assist the trainee in acquiring a faculty position compatible with his/her clinical and research strengths and goals.  When successfully completed, this program will provide trainees with the clinical and academic skills to become Board Certified in Pediatric Hematology/Oncology, and to be competitive for available faculty positions.  The focus of the program will be on training of the fellow and not on filling service needs.

    The educational goals of this program include development of clinical expertise in the discipline of pediatric hematology, oncology, bone marrow transplant, and radiation oncology; development of technical skills in performance of lumbar puncture, bone marrow aspirate and biopsy, and bone marrow harvest for BMT, review and interpretation of peripheral blood smears, cerebrospinal fluid, and bone marrow aspirate; development of scholarship skills; and development of abilities as an educator.

    Our fellows become familiar with all aspects of chemotherapy as well as the pertinent aspects of surgical therapy and radiotherapy in managing patients with malignant diseases. They are also taught the diagnosis, management of complications, and treatment of infections in the compromised host and indications and procedures for transfusion of blood components, including apheresis, and stem cell harvest and infusion. In addition, residents learn to function as a member of a multidisciplinary team serving patients with cancer and chronic hematologic disorders and are guided in the development of skills in communication and counseling, including the recognition and management of psychosocial problems in pediatric patients.

  • Year One

    The first year of the program focuses on an intensive clinical experience. The year begins with an orientation month in which the fellow is introduced to a wide variety of core topics, chemotherapy ordering instruction and procedures to equip the fellow to be successful for the rest of the program. The next 11 months allow the fellow to focus on Inpatient Hematology/Oncology (5 months), Bone marrow transplant and NeuroOncology (3 months), Specialty areas of pediatric pathology, radiation oncology, coagulation and blood banking (1 month), Ambulatory hematology/oncology (2 months) and Vacation (1 month).

    During year one the fellow will be assigned to continuity clinic one day each week when they will see all new patients identified on the inpatient service under the supervision of an attending pediatric hematologist/oncologist. 

    Years Two and Three

    During year 2 and 3 of the program the fellow will undertake an in-depth study of a specific area of pediatric hematology and oncology under the supervision of a Scholarship Oversight Committee. This project may involve laboratory based research in one of the many labs in the UAB Comprehensive Cancer Center as well as labs in the numerous "Centers" housed at UAB. Clinical research projects in numerous areas of Pediatric Hematology/Oncology are ongoing within the division and campus which are also available for the fellow. In some circumstances the fellow may obtain a Masters of Science in Public Health or a PhD degree as a component of the fellowship program. During these years the fellow continues to see their own patients in a weekly continuity clinic.

  • Children's of Alabama is the only tertiary care children's hospital in Alabama with 250 beds. The hospital sits prominently on the Campus of the University of Alabama at Birmingham. The Department of Pediatrics of UAB School of Medicine is housed at Children's of Alabama. The hospital has a 20 bed pediatric hematology/oncology floor, an 8 bed Pediatric Bone marrow Transplant unit, and a 20 bed PICU. A new 350 bed ($500 million) hospital is currently under construction to provide to latest state of the art facilities and is expected to open in 2012.

    The Alabama Center for Childhood Cancer and Blood Disorders at Children's is a component of the UAB Comprehensive Cancer Center, as designated by the National Institute of Health, is the state's only comprehensive center for pediatric blood and malignant disorders, treating 90 percent of all pediatric cancer and other blood disorders patients diagnosed in Alabama. We are the single largest provider of specialized pediatric services in Alabama for: Cancer/Leukemia Brain and Spinal Cord Tumors, pediatric bone marrow transplantation, Sickle Cell Diseases Hemophilia and Other Bleeding Disorders. 

    In 2010, the Division of Pediatric Hematology and Oncology provided care to:

    • 130 children newly diagnosed with cancer

    • 300 cancer patients actively being treated

    • 1,000 survivors of childhood cancer and their families (i.e., children who were previously treated and/or those whose condition is currently being monitored)

    • 13,000+ outpatient clinic visits

    • 2000+ patients treated for serious blood disorders including sickle cell disease, hemophilia and bleeding disorders. 

    The Division of is an active member institution of Children's Oncology Group (COG), an international 200- member collaborative academic research group focused on clinical trials in childhood cancer. Recently, the Division has been awarded membership in the COG Phase I Consortium. This prestigious designation is important as the UAB Division of pediatric Hematology/Oncology is one of only 21 COG Phase I Consortium Sites in the United States and now can provide new and innovative therapies for children with cancer.

    More than 1,000 cancer survivors are participants in our Taking on Life after Cancer (TLC) program. This is the only clinic in Alabama dealing with not only the medical and physical treatment, but also the emotional needs of childhood cancer and bone marrow transplant survivors.

  • Fellows Conference

    Covers core topics in Pediatric Hematology/Oncology

    Research Conference

    Alternates with fellow's conference and exposes the fellow to the breadth of ongoing basic and clinical research within the division and at UAB. Invited guests frequently present at this conference and provide the fellow with exposure to research taking place outside of UAB.

    Tumor Board

    A weekly evidence-based medicine conference involving the multidisciplinary care team designed around the discussion and planning of treatment for patients with new and complex oncologic diseases. The fellows assume a major responsibility for the presentation and discussion.

    Morphology rounds

    Weekly sessions at the microscope with senior faculty to review blood cell identification and characteristics.

Our Team

Kimberly Whelan, M.D.

Kimberly Whelan, M.D.

Fellowship Program Director

Hilary Haines, M.D.

Hilary Haines, M.D.

Assistant Fellowship Program Director

Sherterica Evans

Sherterica Evans

Fellowship Program Coordinator


Complete this form to contact us

Full Name(*)
Please type your full name.

Invalid email address.

Invalid Input

Invalid Input